From WikiHealthAnimi-3Related Topics
Sponsor Links
Launched in 2004, Animi-3 is available by prescription and contains DHA and EPA omega-3 fatty acids and a combination of essential B vitamins: prescription strength folic acid, vitamin B6 and vitamin B12. The omega-3 in Animi-3 is pharmaceutical grade and DHA-dominant. Each Capsule of Animi-3 contains:
Animi-3 capsules are indicated for nutritional support and folic acid supplementation and provide dosing control for these nutrients. Clinical TrialPBM Pharmaceuticals, the maker of Animi-3, is conducting a new study for cardiovascular risk reduction and dementia by a leading heart disease specialist. The Animi-3 clinical study is a six-month, double-blind, randomized, placebo-controlled trial in 75 subjects ages 55-80 years with no prior history of dementia. The study is being conducted by Ernst J. Schaefer, M.D., of Cardiovascular Research Associates, in Boston, MA. Dr. Schaefer is also a Professor of Medicine at Tufts University School of Medicine. Side EffectsContraindications This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. Precautions Folic Acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematological remission can occur while neurological manifestations remain progressive. Pediatric Use Safety and effectiveness in pediatric patients have not been established. Adverse Reactions Allergic sensitization has been reported following oral, enteral and parenteral administration of folic acid. ReferencesPage Statistics
|
||
